SGB not only reduces the patient’s dependence on medications but may also indirectly affect emotional regulation areas in the brain through the modulation of the central nervous system, providing a new perspective for treating anxiety-related sleep disorders (28). The gene discussed is GPC3; the disease is Anxiety.